BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31367187)

  • 1. Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIP
    Francois RA; Zhang A; Husain K; Wang C; Hutchinson S; Kongnyuy M; Batra SK; Coppola D; Sebti SM; Malafa MP
    Cancer Cell Int; 2019; 19():189. PubMed ID: 31367187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia.
    Springett GM; Husain K; Neuger A; Centeno B; Chen DT; Hutchinson TZ; Lush RM; Sebti S; Malafa MP
    EBioMedicine; 2015 Dec; 2(12):1987-95. PubMed ID: 26844278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin E δ-tocotrienol prolongs survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model of pancreatic cancer.
    Husain K; Centeno BA; Chen DT; Hingorani SR; Sebti SM; Malafa MP
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1074-83. PubMed ID: 23963802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGR-1/Bax pathway plays a role in vitamin E δ-tocotrienol-induced apoptosis in pancreatic cancer cells.
    Wang C; Husain K; Zhang A; Centeno BA; Chen DT; Tong Z; Sebti SM; Malafa MP
    J Nutr Biochem; 2015 Aug; 26(8):797-807. PubMed ID: 25997867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasis.
    Husain K; Centeno BA; Coppola D; Trevino J; Sebti SM; Malafa MP
    Oncotarget; 2017 May; 8(19):31554-31567. PubMed ID: 28404939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-FLIP degradation mediates sensitization of pancreatic cancer cells to TRAIL-induced apoptosis by the histone deacetylase inhibitor LBH589.
    Kauh J; Fan S; Xia M; Yue P; Yang L; Khuri FR; Sun SY
    PLoS One; 2010 Apr; 5(4):e10376. PubMed ID: 20442774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW; Shah S
    Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis.
    Raja SM; Chen S; Yue P; Acker TM; Lefkove B; Arbiser JL; Khuri FR; Sun SY
    Mol Cancer Ther; 2008 Jul; 7(7):2212-23. PubMed ID: 18645030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression.
    Lee J; Hwangbo C; Lee JJ; Seo J; Lee JH
    Oncol Rep; 2010 Jan; 23(1):229-37. PubMed ID: 19956887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and safety of vitamin E δ-tocotrienol after single and multiple doses in healthy subjects with measurement of vitamin E metabolites.
    Mahipal A; Klapman J; Vignesh S; Yang CS; Neuger A; Chen DT; Malafa MP
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):157-65. PubMed ID: 27278668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumor cells for TRAIL-induced apoptosis.
    Siegmund D; Hadwiger P; Pfizenmaier K; Vornlocher HP; Wajant H
    Mol Med; 2002 Nov; 8(11):725-32. PubMed ID: 12520089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cells.
    Zhao L; Yue P; Lonial S; Khuri FR; Sun SY
    Mol Cancer Ther; 2011 Dec; 10(12):2415-25. PubMed ID: 21914854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells.
    Shah S; Sylvester PW
    Exp Biol Med (Maywood); 2004 Sep; 229(8):745-55. PubMed ID: 15337828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of c-FLIP(L) and c-FLIP(S) as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells.
    Haag C; Stadel D; Zhou S; Bachem MG; Möller P; Debatin KM; Fulda S
    Gut; 2011 Feb; 60(2):225-37. PubMed ID: 20876774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition.
    Yao W; Yue P; Khuri FR; Sun SY
    Oncotarget; 2015 Oct; 6(33):34669-79. PubMed ID: 26415225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation.
    Fan S; Li Y; Yue P; Khuri FR; Sun SY
    Neoplasia; 2010 Apr; 12(4):346-56. PubMed ID: 20360945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-tocotrienol promotes TRAIL-induced apoptosis through reactive oxygen species/extracellular signal-regulated kinase/p53-mediated upregulation of death receptors.
    Kannappan R; Ravindran J; Prasad S; Sung B; Yadav VR; Reuter S; Chaturvedi MM; Aggarwal BB
    Mol Cancer Ther; 2010 Aug; 9(8):2196-207. PubMed ID: 20682650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel Akt inhibitor API-1 induces c-FLIP degradation and synergizes with TRAIL to augment apoptosis independent of Akt inhibition.
    Li B; Ren H; Yue P; Chen M; Khuri FR; Sun SY
    Cancer Prev Res (Phila); 2012 Apr; 5(4):612-20. PubMed ID: 22345097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.